KALA BIO

Development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles.

Launch date

2009

Employees

Market cap

Enterprise valuation

€14m (Public information from Sep 2024)

Waltham Massachusetts (HQ)

http://kalarx.com

https://twitter.com/kalapharma https://www.linkedin.com/company/kala-pharmaceuticals

Authorizing premium user...